Zachary Gilroy

Zachary Gilroy, CFA has a diverse work experience in various finance roles. Zachary is currently the Head of Finance Business Partner at Amylyx Pharmaceuticals, a position they started in December 2021. Before that, they worked at Alaunos Therapeutics as the Director of Corporate Finance from December 2020 to December 2021, and as an Associate Director of Corporate Finance from October 2019 to December 2020. Zachary also served as the Manager of Financial Planning and Analysis at Organogenesis from October 2018 to October 2019. Prior to that, they worked at The Hanover Insurance Group as a Senior Analyst in Corporate Development & Strategy from June 2017 to October 2018. Additionally, they gained valuable experience in equity research as a Global Markets Summer Associate at RBC Capital Markets in 2015. Zachary'scareer started at RSM US LLP, where they worked in various roles including Supervisor in Transaction Advisory Services from April 2012 to August 2014, Senior Associate in Assurance from September 2009 to April 2012, and Associate in Assurance from September 2007 to September 2009. Throughout their career, Zachary has focused on financial statement audits of financial services companies, with a primary emphasis on investment valuation analysis.

Zachary Gilroy, CFA holds a Master of Business Administration (MBA) degree from the University of Michigan - Stephen M. Ross School of Business, earned between 2014 and 2016. Prior to that, they obtained a Master of Science (M.S.) degree in Accounting from Fairfield University in 2008, following the completion of their Bachelor of Science (B.S.) in Accounting, which they received in 2007 from the same institution.